Cardiac cytokine therapy? Relevance of targeting inflammatory mediators to combat cardiac arrhythmogenic remodeling
Author:
Open Access
- 18 November 2021
- journal article
- editorial
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 37, 100918
Abstract
No abstract availableKeywords
Funding Information
- Fondation Institut de Cardiologie de Montréal
This publication has 21 references indexed in Scilit:
- Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial FibrillationCirculation, 2018
- Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic ImplicationsFrontiers in Physiology, 2018
- Elevated plasma levels of Th17-related cytokines are associated with increased risk of atrial fibrillationScientific Reports, 2016
- Pro-resolving lipid mediators are leads for resolution physiologyNature, 2014
- Natural resolution of inflammationPeriodontology 2000, 2013
- Could interferon-gamma be a therapeutic target for treating heart failure?Heart Failure Reviews, 2013
- MyocarditisNew England Journal of Medicine, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul StudyAmerican Heart Journal, 2008
- The Journal of InflammationJournal of Inflammation, 2004